title: Viewpoint: megatrials and the development of antithrombotics.
authors.forename: Monika
authors.initials: M
authors.lastname: Polak
mesh_terms: D003327:Coronary Disease / Q000188:drug therapy / Q000191:economics; D003328:Coronary Thrombosis / Q000188:drug therapy* / Q000191:economics; D003953:Diagnosis-Related Groups; D004305:Dose-Response Relationship, Drug; D004345:Drug Industry / Q000191:economics; D005343:Fibrinolytic Agents / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D015337:Multicenter Studies as Topic / Q000639:trends*; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D018401:Sample Size
chemical_list: D005343:Fibrinolytic Agents